FDA approves new weight-loss drug Zepbound
Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk's Wegovy, a high-dose version of its diabetes treatment Ozempic. Both are weekly injections.
Top Videos
FDA approves new weight-loss drug Zepbound
Man shot execution style, killed, while on bike in South Philly
Family files lawsuits over horrific death of Chester County girl
